OKYO Pharma Ltd ADR Net Asset Quality Index
OKYO Pharma Ltd ADR net asset quality index. OKYO Pharma Ltd ADR (OKYO) has a Net Asset Quality Index of 58.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $20.98 Million minus total liabilities of $8.64 Million yields net assets of $12.34 Million. A higher index indicates a stronger, lower-leverage balance sheet. See OKYO Pharma Ltd ADR book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of OKYO Pharma Ltd ADR (2008–2026)
Net asset quality index of OKYO Pharma Ltd ADR from 2008 to 2026. This chart shows how OKYO Pharma Ltd ADR's Net Asset Quality Index has evolved across 19 annual periods from 2008 to 2026. As of June 2026, the index stands at 58.8%, representing net assets of $12.34 Million against total assets of $20.98 Million USD. Check OKYO strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
OKYO Pharma Ltd ADR Net Asset Quality Index by Year (2008–2026)
OKYO Pharma Ltd ADR net asset quality index by year from 2008 to 2026. The table below presents the year-by-year Net Asset Quality Index for OKYO Pharma Ltd ADR from 2008 to 2026, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see OKYO market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 58.8% | $12.34 Million | $20.98 Million | $8.64 Million | ▲ +209.7 pp |
| 2025 | -150.9% | $-5.55 Million | $3.68 Million | $9.23 Million | ▲ +230.6 pp |
| 2024 | -381.5% | $-5.88 Million | $1.54 Million | $7.42 Million | ▼ -342.0 pp |
| 2023 | -39.5% | $-2.05 Million | $5.20 Million | $7.26 Million | ▼ -108.0 pp |
| 2022 | 68.5% | $2.95 Million | $4.30 Million | $1.35 Million | ▼ -6.5 pp |
| 2021 | 75.0% | $5.32 Million | $7.09 Million | $1.77 Million | ▲ +98.4 pp |
| 2020 | -23.4% | $-139.80K | $597.40K | $737.20K | ▼ -67.2 pp |
| 2019 | 43.8% | $333.14K | $759.86K | $426.72K | ▼ -51.6 pp |
| 2018 | 95.5% | $1.92 Million | $2.01 Million | $91.06K | ▼ -3.6 pp |
| 2017 | 99.1% | $27.50 Million | $27.76 Million | $258.76K | ▼ -0.4 pp |
| 2016 | 99.4% | $32.00 Million | $32.18 Million | $181.34K | ▼ -0.1 pp |
| 2015 | 99.6% | $33.90 Million | $34.05 Million | $151.07K | ▲ +0.1 pp |
| 2014 | 99.5% | $46.96 Million | $47.21 Million | $247.95K | ▼ -0.1 pp |
| 2013 | 99.6% | $45.02 Million | $45.20 Million | $183.32K | ▲ +1.6 pp |
| 2012 | 98.0% | $41.36 Million | $42.20 Million | $832.89K | ▼ -1.5 pp |
| 2011 | 99.5% | $16.01 Million | $16.09 Million | $78.74K | ▼ -0.3 pp |
| 2010 | 99.9% | $54.05 Million | $54.13 Million | $79.87K | ▲ +0.1 pp |
| 2009 | 99.8% | $38.18 Million | $38.27 Million | $85.96K | ▲ +0.3 pp |
| 2008 | 99.5% | $27.46 Million | $27.60 Million | $144.86K | — |